People: Bovie Medical Corp (BVX)

BVX on American Stock Exchange

3.92USD
17 Apr 2014
Price Change (% chg)

$-0.06 (-1.51%)
Prev Close
$3.98
Open
$3.94
Day's High
$4.01
Day's Low
$3.81
Volume
9,576
Avg. Vol
28,223
52-wk High
$4.79
52-wk Low
$1.94

Search Stocks

Summary

Name Age Since Current Position

Andrew Makrides

71 2013 Executive Chairman of the Board

J. Robert Saron

60 2011 President, Chief Sales and Marketing Officer, Director

Robert Gershon

2013 Chief Executive Officer, Director

Gary Pickett

61 2009 Chief Financial Officer, Treasurer, Secretary

Moshe Citronowicz

60 2011 Senior Vice President

Jack McCarthy

47 2014 Chief Commercialization Officer

Ian Sheffield

2013 Director

Michael Geraghty

65 2011 Independent Director

Lawrence Waldman

66 2011 Independent Director

Joseph Vazquez

IR Contact Officer

Biographies

Name Description

Andrew Makrides

Mr. Andrew Makrides, Esq., is an Executive Chairman of the Board of Bovie Medical Corp. He received a Bachelor of Arts degree in Psychology from Hofstra University and a Juris Doctor Degree from Brooklyn Law School. He is a member of the Bar of the State of New York and practiced law from 1968 until joining Bovie Medical Corporation as a co-founder and Executive Vice President and director, in 1982. Mr. Makrides became President of the Company in 1985 and the CEO in December 1998 and has served as such until March 18, 2011 at which point he relinquished his position as President, but remained CEO. Mr. Makrides employment contract extends to December 31, 2015. Mr. Makrides has over 29 years of executive experience in the medical industry.

J. Robert Saron

Mr. J. Robert Saron is President, Chief Sales and Marketing Officer, Director of Bovie Medical Corp. He holds a Bachelor degree in Social and Behavioral Science from the University of South Florida. From 1988 to present Mr. Saron has served as a director of the Company. Mr. Saron has previously served on two industry boards. He served as both director and president of the Health Care Manufacturing Management Council. In 2011 Mr. Saron received the Leonard Berke Achievement award for ethics, mentoring, marketing skill, industry knowledge, contributions to the industry and contributions to HMMC. He also served as a director of the Health Industry Distributors Association Education Foundation. Mr. Saron also received the Health Industry Distributors Association’s highest award in 2008, the Industry Award of Distinction, and in February 2013 was inducted into the Medical Distribution Hall of Fame. Mr. Saron’s employment contract extends to December 31, 2015. Mr. Saron brings over 34 years of executive marketing and distribution experience in the medical industry.

Robert Gershon

Mr. Gershon has over 25 years of healthcare industry experience. On the operations side he ran the largest sales and marketing business at Covidien. With over $1B in P&L responsibility he consistently led an organization of over 600 people to double-digit revenue growth outpacing market category growth and capturing significant market share points during challenging healthcare economic conditions. He also was VP of sales and marketing at Henry Schein ($1.4B shared P&L for medical division/$115M full P&L for dialysis division) and earlier in his career spent over 13 years as a healthcare consultant for Booz, Allen, KPMG and two boutique consultancies where his practice focused on strategic planning, business development and mergers and acquisitions. Mr. Gershon received an MBA from J.L. Kellogg Graduate School of Management at Northwestern University and a BSBA degree from American University. He is Chief Executive Officer, Director of the Company.

Gary Pickett

Mr. Gary D. Pickett, CPA, is Chief Financial Officer, Treasurer, Secretary of Bovie Medical Corp. He holds an MBA from the University of Tampa, a BS degree in Accounting from Florida State University, and served five years as a field artillery officer in the United States Army. Mr. Pickett joined as controller of Bovie in March 2006 and became Chief Financial Officer in October 2006. During the five years prior to joining Bovie, Mr. Pickett held positions of Director of Financial Systems with Progress Energy Services of Raleigh, NC, Vice President and Controller of Progress Rail Services, a subsidiary of Progress Energy Services in Albertville, AL, each of which were non-affiliated with Bovie. He has had experience in Sarbanes-Oxley implementation as well as GAAP accounting and SEC Reporting.

Moshe Citronowicz

Mr. Moshe Citronowicz is Senior Vice President of Bovie Medical Corporation. He has worked in a variety of manufacturing and high technology industries. In October 1993, Mr. Citronowicz joined the Company as Vice President of Operations and served as Chief Operating Officer until November 2011. Currently, he is serving as the Senior Vice President.

Jack McCarthy

Mr. Jack McCarthy is Chief Commercialization Officer of the Company. Mr. McCarthy has 23 years of sales and marketing experience of which the last 16 years has been spent in the healthcare industry. Most recently, he served as Vice President of Sales and Marketing for US Healthcare at Z-Medica. Prior to that, Mr. McCarthy spent 15 years with Covidien (NYSE:COV), in positions of increasing responsibility where he was charged with achieving sales and business development goals. His most recent position at Covidien was as Area Sales Vice President for the Endo Mechanical Intelligent Device franchise, where he managed a team of 50 sales professionals. Mr. McCarthy is a graduate of Loyola College in Baltimore, Maryland, where he obtained a BA degree in Marketing in 1988 and an MBA in Marketing in 1990.

Ian Sheffield

Ian Sheffield currently serves as a Senior Associate at Great Point Partners, Greenwich, CT. As part of his investment functions, he leads Great Point Partners’ medical devices and diagnostics investing efforts in public companies. Prior to joining Great Point, he served in various capacities at Versant Ventures, Medtronic, and Procter & Gamble. He holds a B.S. from Miami University and an M.B.A. from the Harvard Business School. He is Director of the Company.

Michael Geraghty

Mr. Michael E. Geraghty is Independent Director of Bovie Medical Corporation. He has served as a director since March 2011 and is the Executive Vice President of Global Sales at Optos, Inc., a developer and manufacturer of retinal imaging devices for screening, detection and diagnosis of eye related conditions. From 2005 through 2008, he was the President of International Sales at Gyrus Acmi where he first started in 2000 as Senior Vice President of Sales for Gyrus Medical. Prior to this, Mr. Geraghty was the Vice President of Sales and Marketing for Everest Medical, Inc. and before that was the Director of Marketing for Advanced Products at Arthrocare Corporation. Mr. Geraghty specializes in building independent direct sales teams in the medical device industry and has domestic and international sales and marketing experience. He received his bachelor’s degree from St. Mary’s University and graduate degree in Executive Sales Management from the University of Minnesota.

Lawrence Waldman

Mr. Lawrence J. Waldman, CPA, is Independent Director of Bovie Medical Corporation. He has served as a director since March 2011 and is certified public accountant. Mr. Waldman is currently the Partner-in-Charge of EisnerAmper LLP Commercial Audit Practice Development of the accounting firm EisnerAmper LLP. He has over thirty-five years of experience in public accounting, including twenty-five years experience as an audit partner serving a wide range of clients. Prior to joining EisnerAmper LLP, Mr. Waldman was the Partner-in-Charge of Commercial Audit Practice Development for Holtz Rubenstein Reminick, LLP. Mr. Waldman was the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he started at in 1972. Mr. Waldman is also the Chairman of the Board of Trustees of the Long Island Power Authority and serves on the Finance and Audit Committee of the Board of Trustees. He is currently the Treasurer of the Long Island Association as well as a member of its Board of Directors and Chairman of the Finance Committee. In addition, Mr. Waldman is a member of the Board of Directors and Treasurer of each of the Long Island Angel Network and the Advanced Energy research Center at Stony Brook University and a member of the Dean’s Advisory Board of the Hofstra University Frank G. Zarb School of Business. Mr. Waldman received his bachelor’s degree and MBA from Hofstra University where he is also an adjunct professor. Mr. Waldman also serves on the Audit Committee.

Joseph Vazquez

Basic Compensation

Options Compensation

Name Options Value

Andrew Makrides

882,900 6,531,250

J. Robert Saron

650,400 4,422,480

Robert Gershon

0 0

Gary Pickett

195,000 1,156,850

Moshe Citronowicz

517,900 4,290,050

Jack McCarthy

0 0

Ian Sheffield

0 0

Michael Geraghty

0 0

Lawrence Waldman

0 0

Joseph Vazquez

0 0
Search Stocks